13th Annual AKI Symposium
To continue to foster cross-campus research collaboration on acute kidney injury and further AKI awareness, education, and advocacy.
This symposium will promote the clinical knowledge related to diagnosis and personalized treatment of acute kidney injury (AKI). It will help to improve the care of critically ill patients who develop or are at risk for AKI. It will also promote communication and collaboration among experts and specialists treating and researching acute kidney injury. The understanding of AKI and the effective strategies for developing, implementing, and performing protocols for managing the condition will be enhanced.
Target Audience
The symposium is targeted for doctors, fellows, researchers, and professionals in the medical and research fields of critical care medicine, transplantation, nephrology, and the renal-electrolyte division. The symposium also serves as a platform to spread kidney awareness and to educate and share resources with patients and the community.
Additional Information
Attachment | Size |
---|---|
13th AKI Symposium Agenda_V2 (005).pdf | 227.21 KB |
Course Director(s):
Raghavan Murugan, MD, MS, FRCP, FCCM
Professor, Critical Care Medicine & Clinical and Translational Science Chief, Critical Care Medicine |UPMC Magee Womens Hospital Director, Program for Critical Care Nephrology |University of Pittsburgh School of Medicine
Roderick Tan, MD, PhD
Assistant Professor of Medicine, Renal-Electrolyte Division
Jacqueline Ho, MD, MSc
Director of Pediatric Nephrology Fellowship, Pediatric Nephrology
Martin Oberbarnscheidt, MD, PhD
Assistant Professor of Surgery, Starzl Transplantation Institute
Faculty Disclosure
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships for the individuals listed below have been mitigated:
1. Dr. Raghavan Murugan had grant/research support from Baxter inc. The financial relationship ended in June of 2022.
2. Dr. Sandy Kane-Gill is on the Executive Committee of the Society of Critical Care Medicine and has grant support from the Jewish Healthcare Society.
3. Dr. Mohamed Ezzelarab is a consultant for SAB Therapeutics.
4. Dr. Ravindra Mehta is a consultant for the following: Baxter, AM Pharma, Biomerieux, Mallinckrodt, GE Healthcare, Abiomed, NovaBiomed, Novartis, Renasym, Renibus, Alexxion, Guard, Fresenius, Sphingotec.
5. Dr. Sarah Gaffen is a consultant for Trotana Pharmaceuticals.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 5.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 5.50 Attendance
We gratefully acknowledge support from Baxter Healthcare Corp. for their educational grant.
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by e-mailing Maria Delesio at mariadelesio@pitt.edu.
Cancellation requests can be made to:
Maria Delesio
Admin Coordinator, Research
Renal-Electrolyte Division
University of Pittsburgh
412-383-9753
mariadelesio@pitt.edu